These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2632086)

  • 1. Effect of gastric acidity on bioavailability of N,N-dimethylcarbamoylmethylalpha, 2-dimethyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetate, a new prodrug-type anti-inflammatory agent.
    Yamada I; Goda T; Kawata M; Mizuta H; Ogawa K; Yokobe T
    Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3372-5. PubMed ID: 2632086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dissolution properties and bioavailability of ground mixture of N,N-dimethylcarbamoylmethyl alpha, 2-dimethyl-5H-[1]benzopyrano[2,3-b]-pyridine-7-acetate with various pharmaceutical ingredients].
    Yamada I; Kawata M; Shibata T; Ogawa K; Yokobe T
    Yakugaku Zasshi; 1989 Dec; 109(12):932-7. PubMed ID: 2630636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic behaviour in polymorphonuclear leucocytes of N,N-dimethylcarbamoylmethyl alpha,2-dimethyl-5H-[1]benzopyrano[2,3-b]- pyridine-7-acetate (Y-23023), a new prodrug type of anti-inflammatory agent, and indomethacin after oral administrations in rats.
    Yamada I; Nagamatsu Y; Imayoshi T; Shibata M; Tsuji A
    J Pharm Pharmacol; 1994 Jul; 46(7):614-6. PubMed ID: 7996395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthesis, pharmacological activity and biopharmaceutical characteristics of alpha,2-dimethyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetates].
    Kawasaki K; Yamada I; Oe T; Tsuruda M; Terasawa M; Imayoshi T; Yasunaga Y; Goto K
    Yakugaku Zasshi; 1989 Nov; 109(11):827-34. PubMed ID: 2614665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of gastric acidity-controlled beagle dog to bioavailability study of cinnarizine].
    Yamada I; Goda T; Kawata M; Ogawa K
    Yakugaku Zasshi; 1990 Apr; 110(4):280-5. PubMed ID: 2376821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal physiology-regulated dogs for bioavailability evaluation of an oral controlled-release dosage form composed of pulsatile release granules.
    Sagara K; Yamada I; Matsuura Y; Kawata M; Shibata M
    Biol Pharm Bull; 1996 Sep; 19(9):1184-8. PubMed ID: 8889038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric acidity-dependent bioavailability of commercial sustained release preparations of indomethacin, evaluated by gastric acidity-controlled beagle dogs.
    Yamada I; Goda T; Kawata M; Shiotuki T; Ogawa K
    Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3112-5. PubMed ID: 2085896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.
    Miner PB; Fort JG; Zhang Y
    Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bioavailability of diazepam from uncoated tablets in humans--Part II: effect of gastric fluid acidity.
    Ogata H; Aoyagi N; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):166-70. PubMed ID: 7076346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric antisecretory agents. 1. Antisecretory and antiulcer activity of 5H-[1]benzopyrano[2,3-b]pyridin-5-ylureas and 5H-[1]benzothiopyrano[2,3-b]pyridin-5-ylureas.
    Bristol JA; Gold EH; Lovey RG; Long JF
    J Med Chem; 1981 Aug; 24(8):927-32. PubMed ID: 7328596
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastric antisecretory agents. 2. Antisecretory activity of 9-[(aminoalkyl)thio]-9H-xanthenes and 5-[(aminoalkyl)thio]-5H-[1]benzopyrano[2,3-b]pyridines.
    Bristol JA; Gold EH; Gross I; Lovey RG; Long JF
    J Med Chem; 1981 Aug; 24(8):1010-3. PubMed ID: 7328593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric pH profile and its control in fasting beagle dogs.
    Yamada I; Mizuta H; Goda T; Haga K; Ogawa K
    Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2539-41. PubMed ID: 2605707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Acid Tolerance of Drugs Using Rats and Dogs Controlled for Gastric Acid Secretion.
    Kosugi Y; Yamamoto S; Sano N; Furuta A; Igari T; Fujioka Y; Amano N
    J Pharm Sci; 2015 Sep; 104(9):2887-93. PubMed ID: 25720462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of gastric pH on the absorption of controlled-release theophylline dosage forms in humans.
    Meyer MC; Straughn AB; Jarvi EJ; Wood GC; Vashi VI; Hepp P; Hunt J
    Pharm Res; 1993 Jul; 10(7):1037-45. PubMed ID: 8378245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and in vitro and in vivo availability of diclofenac sodium enteric-coated beads.
    Hosny EA; el-Mahrouk GM; Gouda MW
    Drug Dev Ind Pharm; 1998 Jul; 24(7):661-6. PubMed ID: 9876511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of indomethacin capsules in humans (III): Correlation with bioavailability in beagle dogs.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A; Nakata H; Tsutsumi J; Fujita T; Amada I
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):578-84. PubMed ID: 4077308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of small intestinal transit time on gastrointestinal absorption of 2-[3-(3,5-di-tert-butyl-4-hydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-1-yl ] ethyl acetate, a new non-steroidal anti-inflammatory agent.
    Mizuta H; Kawazoe Y; Ogawa K
    Chem Pharm Bull (Tokyo); 1990 Oct; 38(10):2825-8. PubMed ID: 2076568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil.
    Sommers DK; van Wyk M; Moncrieff J; Schoeman HS
    Br J Clin Pharmacol; 1984 Oct; 18(4):535-9. PubMed ID: 6091711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of gastric acidity on the bioavailability of digoxin.
    Cohen AF; Kroon R; Schoemaker R; Hoogkamer H; van Vliet A
    Ann Intern Med; 1991 Oct; 115(7):540-5. PubMed ID: 1883123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric-acidity-controlled rabbits: control of gastric pH of rabbits by the use of antacids.
    Takahashi T; Uezono Y; Nakanishi Y
    Chem Pharm Bull (Tokyo); 1987 Apr; 35(4):1546-54. PubMed ID: 3652295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.